These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33946884)

  • 1. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells.
    Santolla MF; Talia M; Maggiolini M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
    Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway.
    Dukhanina EA; Portseva TN; Dukhanin AS; Georgieva SG
    Cell Adh Migr; 2022 Dec; 16(1):65-71. PubMed ID: 35546077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Lappano R; Talia M; Cirillo F; Rigiracciolo DC; Scordamaglia D; Guzzi R; Miglietta AM; De Francesco EM; Belfiore A; Sims AH; Maggiolini M
    J Exp Clin Cancer Res; 2020 Aug; 39(1):153. PubMed ID: 32778144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.
    Feng L; Liao WX; Luo Q; Zhang HH; Wang W; Zheng J; Chen DB
    J Cell Physiol; 2012 Jun; 227(6):2480-91. PubMed ID: 21830216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical stimulation facilitates the angiogenesis of human umbilical vein endothelial cells through MAPK/ERK signaling pathway by stimulating FGF2 secretion.
    Geng K; Wang J; Liu P; Tian X; Liu H; Wang X; Hu C; Yan H
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C277-C286. PubMed ID: 30995109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.
    Mueller KL; Madden JM; Zoratti GL; Kuperwasser C; List K; Boerner JL
    Breast Cancer Res; 2012 Jul; 14(4):R104. PubMed ID: 22788954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression.
    Chen G; Tian X; Liu Z; Zhou S; Schmidt B; Henne-Bruns D; Bachem M; Kornmann M
    Br J Cancer; 2010 Jan; 102(1):188-95. PubMed ID: 19920824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role of Hyperglycemia in Fetoplacental Endothelial Dysfunction in Gestational Diabetes Mellitus.
    Zhou J; Ni X; Huang X; Yao J; He Q; Wang K; Duan T
    Cell Physiol Biochem; 2016; 39(4):1317-28. PubMed ID: 27606810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence.
    Lyes MA; Payne S; Ferrell P; Pizzo SV; Hollenbeck ST; Bachelder RE
    Breast Cancer Res Treat; 2019 Apr; 174(2):413-422. PubMed ID: 30594967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
    De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
    Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells.
    Chamorro-Jorganes A; Araldi E; Rotllan N; Cirera-Salinas D; Suárez Y
    J Cell Sci; 2014 Mar; 127(Pt 6):1169-78. PubMed ID: 24463821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
    Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
    Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effects of fibroblast growth factor 2 on proliferation and migration of uterine luminal epithelial cells during early pregnancy.
    Lim W; Bae H; Bazer FW; Song G
    Biol Reprod; 2017 Jan; 96(1):185-198. PubMed ID: 28395342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
    Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
    J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
    Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
    Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.